Brian Wensel

About Brian Wensel

Results-oriented leader with 18+ years of diverse experience in US based Integrated Delivery Networks (IDNs), health plans, Real World Evidence (RWE), Health Economic and Outcomes Research (HEOR) data generation, product launches, account management, and the pharmacy profession. Responsible for the relationship development, management, consultation, and dissemination of RWE and HEOR materials within IDNs, private/public Payers, Pharmacy Benefit Managers (PBMs), Group Purchasing Organizations (GPOs), Accountable Care Organizations (ACOs), and formulary decision makers. Further experience includes building research alliances; developing market access strategies and pull through materials as well as value based contracting, pricing, and reimbursement models across multiple therapeutic areas within the pharmaceutical and healthcare industries. Very tenured experience in building, motivating, and leading highly successful teams.

Experience

1. Value Evidence and Outcomes Liaison at Boehringer Ingelheim Pharmaceuticals, Inc

   Boehringer Ingelheim

   Jan 2024 — Present

   Led and managed national IDNs, regional IDNs, regional payers, national LTC, and national GPO account teams in the communication of pre-approval information exchange (PIE), real-world evidence-based clinical, economic, and humanistic information to C&D suite decision makers• Created and developed BOI, PIE, and payer guidance presentation decks for formulary decision makers• Created and managed research alliances and partnerships with national IDNs and payers• Built, obtained, and managed internal support in a highly matrixed environment for account innovation to help better manage their patient population• Proactively drove support of patient access, formulary access, and optimal reimbursements of products using budget impact & predictive models, cost effectiveness models, population health management, medication therapy management and transition of care programs• Provided clinical education to various types of health care providers within payers’ health services teams and IDNs• Therapeutic areas of responsibility: ILD/IPF/PPF, COPD, cardiovascular, nephrology, metabolic, immunology biologics, oncology, serious mental illness, obesity, MASH • Key product lead for: obesity and MASH

Education

• ACCP

  Board Certified Pharmacotherapy Specialist, Clinical Pharmacology

• The University of Tennessee at Chattanooga

  Pre-Pharmacy Studies

  1998 — 2002

• Auburn University

  Doctor of Pharmacy (PharmD), Pharmacy

  2002 — 2006